Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma.
Oncotarget
; 7(33): 53881-53894, 2016 Aug 16.
Article
in En
| MEDLINE
| ID: mdl-27449089
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Cerebellar Neoplasms
/
Checkpoint Kinase 1
/
Medulloblastoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Oncotarget
Year:
2016
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos